A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Clinical trial NCT06023589 · RECRUITING
Trial details
- NCT number
- NCT06023589
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-24
- Primary completion
- 2028-05-31
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.